Latest News
Arrowhead reports positive Phase 3 results for plozasiran in severe hypertriglyceridaemia
22 July 2026 - Pharmaceutical company Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) reported positive topline results from its Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in patients with severe hypertriglyceridaemia, with both trials meeting ...
Zoetis introduces Portela for feline osteoarthritis pain relief in Canada and EU
22 July 2026 - Animal health company Zoetis Inc (NYSE: ZTS) announced on Wednesday that it has launched Portela (relfovetmab) in Canada and European Union member states, introducing the first long-acting anti-nerve growth factor monoclonal antibody t...
Ipsen completes Memo Therapeutics acquisition to strengthen rare disease pipeline
22 July 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Wednesday that it has completed the acquisition of Memo Therapeutics AG, adding late-stage asset potravitug to its rare disease pipeline.Potravitug is...
Elephas Biosciences partners with Invitrocue to promote elive platform in Singapore and Malaysia
22 July 2026 - Elephas Biosciences Corporation, developer of an innovative live tissue platform for immunotherapy response prediction, announced on Tuesday that it has entered into an international partnership with life sciences company Invitrocue Pt...
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
22 July 2026 - West Pharmaceutical Services Inc (NYSE:WST), a manufacturer of containment and delivery solutions for injectable medicines, announced on Tuesday that its board of directors has declared a regular quarterly dividend of USD0.22 per share...